Breast cancer risk reduction, version 2.2015 clinical practice guidelines in oncology clinical practice guidelines in oncology

Therese B. Bevers, John H. Ward, Banu K. Arun, Graham A. Colditz, Kenneth H Cowan, Mary B. Daly, Judy E. Garber, Mary L. Gemignani, William J. Gradishar, Larissa A. Korde, Nicole Kounalakis, Helen Krontiras, Shicha Kumar, Allison Kurian, Rachel M. Layman, Loretta S. Loftus, Martin C. Mahoney, Sofia D. Merajver, Ingrid M. Meszoely, Joanne MortimerLisa Newman, Elizabeth Pritchard, Sandhya Pruthi, Victoria Seewaldt, Michelle C. Specht, Kala Visvanathan, Anne Wallace, Mary Ann Bergman, Rashmi Kumar

Research output: Contribution to journalReview article

23 Scopus citations

Abstract

Breast cancer is the most frequently diagnosed malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. To assist women who are at increased risk of developing breast cancer and their physicians in the application of individualized strategies to reduce breast cancer risk, NCCN has developed these guidelines for breast cancer risk reduction.

Original languageEnglish (US)
Pages (from-to)880-915
Number of pages36
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume13
Issue number7
DOIs
StatePublished - Jul 1 2015

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Breast cancer risk reduction, version 2.2015 clinical practice guidelines in oncology clinical practice guidelines in oncology'. Together they form a unique fingerprint.

  • Cite this

    Bevers, T. B., Ward, J. H., Arun, B. K., Colditz, G. A., Cowan, K. H., Daly, M. B., Garber, J. E., Gemignani, M. L., Gradishar, W. J., Korde, L. A., Kounalakis, N., Krontiras, H., Kumar, S., Kurian, A., Layman, R. M., Loftus, L. S., Mahoney, M. C., Merajver, S. D., Meszoely, I. M., ... Kumar, R. (2015). Breast cancer risk reduction, version 2.2015 clinical practice guidelines in oncology clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 13(7), 880-915. https://doi.org/10.6004/jnccn.2015.0105